Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine Tertiary Government Hospital
Authors:
Open Access
- 6 February 2025
- journal article
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 19, 1840
Abstract
Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine Tertiary Government Hospital Carl Arenos, Steven LKeywords
This publication has 24 references indexed in Scilit:
- HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancerBreast Cancer Research and Treatment, 2021
- Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscapeESMO Open, 2021
- Impact of menopausal status on risk of metastatic recurrence of breast cancerMenopause, 2021
- Menopausal status at diagnosis of breast cancer and risk of metastatic recurrenceMenopause, 2021
- Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinomaSeminars in Cancer Biology, 2021
- The updated 2018 American Society of Clinical Oncology/College of American Pathologists guideline on human epidermal growth factor receptor 2 interpretation in breast cancer: comparison with previous guidelines and clinical significance of the proposed in situ hybridization groupsHuman Pathology, 2020
- Promoting Breast Cancer Awareness and Screening Practices for Early Detection in Low-Resource SettingsEuropean Journal of Breast Health, 2019
- Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 DatabasePLOS ONE, 2016
- HER2 in Breast CancerAdvances in Anatomic Pathology, 2014
- Significance of immunohistochemistry in breast cancerWorld Journal of Clinical Oncology, 2014